Selective Catalyst Reduction(SCR)Urea Dosing System(UDS)directly affects the system accuracy and the dynamic response performance of a vehicle.However,the UDS dynamic response is hard to keep up with the changes o...Selective Catalyst Reduction(SCR)Urea Dosing System(UDS)directly affects the system accuracy and the dynamic response performance of a vehicle.However,the UDS dynamic response is hard to keep up with the changes of the engine's operating conditions.That will lead to low NO_χconversion efficiency or NH_3 slip.In order to optimize the injection accuracy and the response speed of the UDS in dynamic conditions,an advanced control strategy based on an air-assisted volumetric UDS is presented.It covers the methods of flow compensation and switching working conditions.The strategy is authenticated on an UDS and tested in different dynamic conditions.The result shows that the control strategy discussed results in higher dynamic accuracy and faster dynamic response speed of UDS.The inject deviation range is improved from being between-8%and 10%to-4%and 2%and became more stable than before,and the dynamic response time was shortened from 200 ms to 150 ms.The ETC cycle result shows that after using the new strategy the NH_3 emission is reduced by 60%,and the NO_χemission remains almost unchanged.The trade-off between NO_χconversion efficiency and NH_3 slip is mitigated.The studied flow compensation and switching working conditions can improve the dynamic performance of the UDS significantly and make the UDS dynamic response keep up with the changes of the engine's operating conditions quickly.展开更多
Objective:To determine the impact of adjunctive Buchang Naoxintong Capsule(步心脑心通胶囊,NXT) on dual antiplatelet therapy in patients with cytochrome P450 2C19*2(CYP2C19*2) polymorphism undergoing percutaneou...Objective:To determine the impact of adjunctive Buchang Naoxintong Capsule(步心脑心通胶囊,NXT) on dual antiplatelet therapy in patients with cytochrome P450 2C19*2(CYP2C19*2) polymorphism undergoing percutaneous coronary intervention(PCI).Methods:Ninety patients with CYP2C19*2 polymorphism were enrolled,and their genotypes were confirmed by polymerase chain reaction(PCR).The patients were randomly assigned to receive either adjunctive NXT(triple group,45 cases) or dual antiplatelet therapy(dual group,45 cases) using a computer-generated randomization sequence and sealed envelopes.Platelet function was assessed at baseline and 7 days after treatment with conventional aggregometry.Subsequent major adverse cardiovascular events(MACE,including sudden cardiac arrest and acute coronary syndrome) were recorded during a 12-month followup.Results:Baseline platelet function measurements were similar in both groups.After 7 days,percent inhibitions of maximum platelet aggregation and late platelet aggregation were significantly greater in the triple versus dual group(42.3%±16.0%vs.20.8%±15.2%,P〈0.01,and 54.7%±18.3%vs.21.5%±29.2%,P〈0.01,respectively).During the 12-month follow-up,the rate of subsequent MACE(6/45) was significantly lower in the triple group compared with the dual group(14/45;P〈0.05).Conclusion:Adjunctive NXT to maintenance dose clopidogrel(75 g) could enhance the antiplatelet effect and decrease subsequent MACE in patients with the CYP2C19'2polymorphism undergoing PCI.展开更多
基金Supported by National Hi-tech Research and Development Program of China(863 Program,Grant No.2012AA111708)
文摘Selective Catalyst Reduction(SCR)Urea Dosing System(UDS)directly affects the system accuracy and the dynamic response performance of a vehicle.However,the UDS dynamic response is hard to keep up with the changes of the engine's operating conditions.That will lead to low NO_χconversion efficiency or NH_3 slip.In order to optimize the injection accuracy and the response speed of the UDS in dynamic conditions,an advanced control strategy based on an air-assisted volumetric UDS is presented.It covers the methods of flow compensation and switching working conditions.The strategy is authenticated on an UDS and tested in different dynamic conditions.The result shows that the control strategy discussed results in higher dynamic accuracy and faster dynamic response speed of UDS.The inject deviation range is improved from being between-8%and 10%to-4%and 2%and became more stable than before,and the dynamic response time was shortened from 200 ms to 150 ms.The ETC cycle result shows that after using the new strategy the NH_3 emission is reduced by 60%,and the NO_χemission remains almost unchanged.The trade-off between NO_χconversion efficiency and NH_3 slip is mitigated.The studied flow compensation and switching working conditions can improve the dynamic performance of the UDS significantly and make the UDS dynamic response keep up with the changes of the engine's operating conditions quickly.
基金Supported by the Provincial Natural Science Foundation of Fujian(No.2011J0133)the National Natural Science Foundation of China(No.81373838)
文摘Objective:To determine the impact of adjunctive Buchang Naoxintong Capsule(步心脑心通胶囊,NXT) on dual antiplatelet therapy in patients with cytochrome P450 2C19*2(CYP2C19*2) polymorphism undergoing percutaneous coronary intervention(PCI).Methods:Ninety patients with CYP2C19*2 polymorphism were enrolled,and their genotypes were confirmed by polymerase chain reaction(PCR).The patients were randomly assigned to receive either adjunctive NXT(triple group,45 cases) or dual antiplatelet therapy(dual group,45 cases) using a computer-generated randomization sequence and sealed envelopes.Platelet function was assessed at baseline and 7 days after treatment with conventional aggregometry.Subsequent major adverse cardiovascular events(MACE,including sudden cardiac arrest and acute coronary syndrome) were recorded during a 12-month followup.Results:Baseline platelet function measurements were similar in both groups.After 7 days,percent inhibitions of maximum platelet aggregation and late platelet aggregation were significantly greater in the triple versus dual group(42.3%±16.0%vs.20.8%±15.2%,P〈0.01,and 54.7%±18.3%vs.21.5%±29.2%,P〈0.01,respectively).During the 12-month follow-up,the rate of subsequent MACE(6/45) was significantly lower in the triple group compared with the dual group(14/45;P〈0.05).Conclusion:Adjunctive NXT to maintenance dose clopidogrel(75 g) could enhance the antiplatelet effect and decrease subsequent MACE in patients with the CYP2C19'2polymorphism undergoing PCI.